STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
234
13F, latest reported quarter
Conversions, 180 days
8
Codes C/M, not in net · $3.2M priced
What the filings say about OUST
Insiders, 180 days
-$37.2M net sold
1 buyer · 9 sellers · 20% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$7.4M
10 notices
Ouster insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Ouster, Inc. insiders sold a net $37.2M of stock across 185 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Aug 18, 2026.
The trade is 6.4% of the 245,328 shares held after it.
5 other insiders sold within 30 days.
234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Gianella Kenneth P. sold about $532.7K of OUST under a 10b5-1 plan on Sep 14, 2026; 5 other insiders sold within 30 days and 234 funds added in the latest 13F quarter.
37 earlier Form 4 trades (code P or S) here by this insider (5 buys, 32 sales), the last on Jun 12, 2026.
-10.1% median (-1.6% mean) 90-day return after 3 previous buys.
The trade is 5.9% of the 318,987 shares held after it.
5 other insiders sold within 30 days.
234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Frichtl Mark sold about $637.7K of OUST under a 10b5-1 plan on Sep 14, 2026; 5 other insiders sold within 30 days and 234 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jun 12, 2026.
The trade is 8.4% of the 105,538 shares held after it.
5 other insiders sold within 30 days.
234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Revenue Officer Jacquemet Cyrille sold about $302.1K of OUST on Sep 14, 2026; 5 other insiders sold within 30 days and 234 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (4 buys, 4 sales), the last on Jun 12, 2026.
-10.1% median (-1.6% mean) 90-day return after 3 previous buys.
The trade is 2.9% of the 1,041,816 shares held after it.
5 other insiders sold within 30 days.
234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Pacala Charles Angus sold about $1.0M of OUST under a 10b5-1 plan on Sep 14, 2026; 5 other insiders sold within 30 days and 234 funds added in the latest 13F quarter.
32 earlier Form 4 trades (code P or S) here by this insider (32 sales), the last on Aug 4, 2026.
The trade is 4.5% of the 286,998 shares held after it.
5 other insiders sold within 30 days.
234 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Operating Officer SPENCER DARIEN sold about $435.0K of OUST under a 10b5-1 plan on Sep 14, 2026; 5 other insiders sold within 30 days and 234 funds added in the latest 13F quarter.
185 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
OUST planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Chung Megan
Filed 2026-09-11
$466.6K
Frichtl Mark
Filed 2026-09-11
$763.0K
Gianella Kenneth P.
Filed 2026-09-11
$637.4K
Jacquemet Cyrille
Filed 2026-09-11
$361.5K
SPENCER DARIEN
Filed 2026-09-11
$520.4K
OUST mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Buffalo Early Stage Growth Fund
$2.2M position · as of 2026-06-30
2.9%
Golden Eagle Dynamic Hypergrowth ETF
$1.9M position · as of 2026-06-30
2.8%
Roundhill Humanoid Robotics ETF
$2.3M position · as of 2026-06-30
2.7%
Penn Capital Special Situations Small Cap Equity Fund
$2.9M position · as of 2026-05-31
2.6%
Strategas Macro Thematic Opportunities ETF
$21.9M position · as of 2026-06-30
2.5%
Corgi Lithography & Semiconductor Photonics ETF
$9.8M position · as of 2026-06-30
2.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $37.2M sold by insiders over 180 days, 234 funds added last quarter, $7.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$204.9M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM OUST
FY Dec 2025
$169.4M
FY Dec 2024
$111.1M
FY Dec 2023
$83.3M
FY Dec 2022
$41.0M
FY Dec 2021
$33.6M
Jun 2026
$54.6M
Mar 2026
$48.6M
Dec 2025
$62.2M
Sep 2025
$39.5M
Jun 2025
$35.0M
Mar 2025
$32.6M
Dec 2024
$30.1M
Sep 2024
$28.1M
At each fiscal year end
Single quarter
Net margin, TTM
-26.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM OUST
FY Dec 2025
-35.6%
FY Dec 2024
-87.3%
FY Dec 2023
-449.2%
FY Dec 2022
-337.7%
FY Dec 2021
-279.9%
Jun 2026
-33.2%
Mar 2026
-36.0%
Dec 2025
+6.4%
Sep 2025
-55.0%
Jun 2025
-58.8%
Mar 2025
-67.5%
Dec 2024
-78.9%
Sep 2024
-91.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$82.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM OUST
FY Dec 2025
-$64.8M
FY Dec 2024
-$37.5M
FY Dec 2023
-$140.9M
FY Dec 2022
-$116.1M
FY Dec 2021
-$75.3M
Jun 2026
-$15.4M
Mar 2026
-$9.8M
Dec 2025
-$37.2M
Sep 2025
-$20.0M
Jun 2025
-$2.2M
Mar 2025
-$5.4M
Dec 2024
-$4.0M
Sep 2024
-$4.3M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2024-12-31 (18 months older than the period end); equity 2026-06-30
Debt to equity OUST
FY Dec 2025
0.00x
FY Dec 2024
0.00x
FY Dec 2023
0.24x
FY Dec 2022
0.23x
FY Dec 2021
0.00x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt OUST
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
-3.14x
FY Dec 2022
-2.80x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-18.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity OUST
FY Dec 2025
-27.3%
FY Dec 2024
-53.8%
FY Dec 2023
-213.0%
FY Dec 2022
-64.1%
FY Dec 2021
-101.7%
Jun 2026
-18.0%
Mar 2026
-25.2%
Dec 2025
-27.3%
Sep 2025
-42.0%
Jun 2025
-47.0%
Mar 2025
-56.8%
Dec 2024
-53.8%
Sep 2024
-61.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-13.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets OUST
FY Dec 2025
-19.3%
FY Dec 2024
-32.0%
FY Dec 2023
-127.5%
FY Dec 2022
-49.1%
FY Dec 2021
-53.1%
Jun 2026
-13.4%
Mar 2026
-17.2%
Dec 2025
-19.3%
Sep 2025
-28.9%
Jun 2025
-29.1%
Mar 2025
-32.5%
Dec 2024
-32.0%
Sep 2024
-38.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital OUST
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-20.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed OUST
FY Dec 2025
-31.1%
FY Dec 2024
-46.6%
FY Dec 2023
-156.9%
FY Dec 2022
-56.8%
FY Dec 2021
-64.1%
Jun 2026
-20.0%
Mar 2026
-28.9%
Dec 2025
-31.1%
Sep 2025
-44.6%
Jun 2025
-44.0%
Mar 2025
-48.9%
Dec 2024
-46.6%
Sep 2024
-51.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing OUST
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.0B
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term debt only, 2024-12-31 (18 months older than the period end), minus cash 2026-06-30
Enterprise value OUST
FY Dec 2025
$1.2B
FY Dec 2024
$562.7M
FY Dec 2023
$305.1M
FY Dec 2022
$1.5B
FY Dec 2021
$8.7B
Jun 2026
$3.9B
Mar 2026
$1.1B
Dec 2025
$1.2B
Sep 2025
$1.5B
Jun 2025
$1.2B
Mar 2025
$428.8M
Dec 2024
$562.7M
Sep 2024
$260.1M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-3.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield OUST
FY Dec 2025
-5.0%
FY Dec 2024
-6.2%
FY Dec 2023
-45.1%
FY Dec 2022
-7.3%
FY Dec 2021
-0.8%
Jun 2026
-2.1%
Mar 2026
-6.0%
Dec 2025
-5.0%
Sep 2025
-2.0%
Jun 2025
-1.2%
Mar 2025
-7.4%
Dec 2024
-6.2%
Sep 2024
-19.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing OUST
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
OUST ranks highest on financial health (99th percentile) and growth (96th), and lowest on profitability (17th), among Industrials peers.
Profitability
17
Inputs
Return on equity-18.0% · 17 pct, sector of 198
Return on assets-13.4% · 20 pct, sector of 224
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-20.0% · 15 pct, sector of 195
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 214
Cash flow to debtno debt to cover
Growth
96
Inputs
Revenue growth, YoY+52.5% · 96 pct, sector of 254
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
36
Inputs
Net Form 4 buying (codes P and S), 180d-$32.4M · 9 pct, sector of 170
Insider buyers, 180d1 · 63 pct, sector of 172
Institutional and government
67
Inputs
Funds adding, latest quarter234 · 64 pct, sector of 201
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$610K · 71 pct, sector of 67
Risk and compliance
59
Inputs
Short interest, % of float+10.5% · 16 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+9.1% · 61 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
OUST filings, in plain words
Are Ouster insiders buying or selling OUST?
In the 180 days to 2026-10-27, Ouster insiders were net sellers, a net $37.2M: $41.8K of purchases and $37.2M of sales reported on Form 4, by 1 buyer and 9 sellers.
Are there planned insider sales of OUST?
Yes. 10 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $7.4M of stock; the latest, by Chung Megan, was filed 2026-09-11.
Read the full summary
In the 180 days to 2026-10-27, Ouster insiders were net sellers of OUST, a net $37.2M across purchases and sales reported on Form 4 by 1 buyer and 9 sellers. Sales outweighed purchases more than tenfold by value. 20% of the 44 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 10 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $7.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.